Pritesh Shah
2020
In 2020, Pritesh Shah earned a total compensation of $5.9M as Chief Commercial Officer at NovoCure, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $450,000 |
|---|---|
| Option Awards | $1,661,147 |
| Salary | $481,250 |
| Stock Awards | $3,333,276 |
| Other | $14,925 |
| Total | $5,940,598 |
Shah received $3.3M in stock awards, accounting for 56% of the total pay in 2020.
Shah also received $450K in non-equity incentive plan, $1.7M in option awards, $481.3K in salary and $14.9K in other compensation.
Rankings
In 2020, Pritesh Shah's compensation ranked 1,760th out of 13,090 executives tracked by ExecPay. In other words, Shah earned more than 86.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,760 out of 13,090 | 87th |
Division Manufacturing | 675 out of 5,621 | 88th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 75 out of 799 | 91st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 39 out of 495 | 92nd |
Industry Surgical and Medical Instruments and Apparatus | 23 out of 313 | 93rd |
Source: SEC filing on April 27, 2021.
Shah's colleagues
We found five more compensation records of executives who worked with Pritesh Shah at NovoCure in 2020.